Clinical Trial Update: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating calcium gluconate and magnesium sulfate to prevent neurotoxicity in patients with colorectal cancer receiving oxaliplatin-based chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• CALCIUM GLUCONATE (Calcium gluconate)
• Magnesium sulfate (magnesium sulfate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Chemotherapeutic Agent Toxicity, Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-05-23